Previous 10 | Next 10 |
Longeveron (NASDAQ: LGVN) , a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has announced the pricin...
2024-04-09 08:26:39 ET More on Pre-market losers & stocks. HUB Cyber Security jumps 39% on QPoint Technologies acquisition Acorda Therapeutics announces Nasdaq delisting notification Financial information for Acorda Therapeutics Financial information for ...
2024-04-09 06:22:00 ET 3 Things That Could Change in the Next Year With Penny Stocks The dynamic landscape of investing in penny stocks is poised for notable shifts in the coming year, presenting both seasoned and novice traders with a plethora of opportunities. Key factors contribu...
MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome ...
2024-04-08 13:31:55 ET DENVER, Colo., Apr 08, 2024 ( 247marketnews.com )- Auddia Inc. (NASDAQ: AUUD ), Kraig Biocraft Laboratories (OTCQB: KBLB ), Longeveron Inc. (NASDAQ: LGVN ), Smart for Life, Inc. (NASDAQ: SMFL ), KULR Technology Group, Inc. (NYSE: ...
2024-04-08 10:21:52 ET More on Longeveron Longeveron Inc. (LGVN) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Longeveron Historical earnings data for Longeveron Financial information for Longeveron Read the full article on...
2024-04-08 10:00:33 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Top ...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) fell 25.0% to $0.0413 on volume of 65,683,376 shares Auddia Inc. (AUUD) rose 239.8% to $4.8594 on volume of 48,119,148 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 0.4% to $3.375 on volu...
2024-04-08 09:10:18 ET Auddia AUUD +123% on bagging a U.S. patent for the core AI technology it uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers. U Power ( UCAR ) +68% after the electric vehicle ( EV ) company announce...
MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that the Company’s CEO, Wa’el Hashad, issued the following letter to Longeveron shareholders. Dear Shareholde...
News, Short Squeeze, Breakout and More Instantly...
Longeveron Inc. Company Name:
LGVN Stock Symbol:
NASDAQ Market:
Phase 2b clinical trial evaluating Lomecel-B TM in rare pediatric disease HLHS on track for completing enrollment by end of 2024 Data from Phase 2a clinical trial evaluating Lomecel-B TM in Alzheimer’s Disease selected for Featured Research Oral Presentation at 2024 Alzheimer...
Longeveron (NASDAQ: LGVN) , a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, is reporting changes on its board of directors. The following transitions on the board have been announced: Richard Kender, retired SVP of bu...
Richard Kender, retired SVP of Business Development and Corporate Licensing for Merck & Co., Inc., has been appointed to the Longeveron Board...